Loading…

The prokineticin Bv8 sensitizes cutaneous terminals of female mice to heat

Background Injection of the noxious peptide Bv8 has previously been shown to induce a biphasic thermal hyperalgesia in rodents, the first peak presumably due to peripheral sensitization. This hypothesis has never been directly confirmed. We have assessed whether Bv8 can indeed sensitize peripheral n...

Full description

Saved in:
Bibliographic Details
Published in:European journal of pain 2016-09, Vol.20 (8), p.1326-1334
Main Authors: Hoffmann, T., Negri, L., Maftei, D., Lattanzi, R., Reeh, P.W.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Injection of the noxious peptide Bv8 has previously been shown to induce a biphasic thermal hyperalgesia in rodents, the first peak presumably due to peripheral sensitization. This hypothesis has never been directly confirmed. We have assessed whether Bv8 can indeed sensitize peripheral nerve fibres in the mouse to heat. Methods We used recordings from single cutaneous fibres, cutaneous calcitonin gene‐related peptide (CGRP) release and immunostaining in nerves and plantar skin to evaluate the Bv8 effects on cutaneous nerves. Results Application of Bv8 at nanomolar concentrations (30–310 nmol/L) to skin preparations significantly increased the heat‐induced discharge, the heat‐induced afterdischarge and reduced threshold temperature of single unmyelinated polymodal fibres. Furthermore, application of Bv8 to hind‐paw skin flaps or trigeminal ganglia significantly elevated their heat‐induced CGRP release. Capsaicin‐induced and to a lesser extent also KCl‐induced CGRP releases were also augmented after Bv8 treatment. Immunohistochemistry revealed co‐localization of prokineticin 2 (Bv8 ortholog in rodents) and CGRP in both plantar skin and nerve tissues. These results confirm that Bv8 sensitizes cutaneous nerve endings to heat, partly, although not exclusively through TRPV1 activation. Conclusion Our results thus support the hypothesis that the first hyperalgesic phase to follow Bv8 injection to hind paws of intact animals is due to peripheral sensitization of nociceptors. What does this study add? Our data provide mechanistic insights into the effect Bv8 application exerts on afferent nerve endings and into the concomitant development of thermal hyperalgesia.
ISSN:1090-3801
1532-2149
DOI:10.1002/ejp.857